
Harrison AI
AI-driven Diagnostics
Information
Harrison.ai – Product Description
Harrison.ai is a global medical AI company advancing the future of radiology through clinically validated, transparent, and scalable artificial intelligence solutions. Formerly known as Annalise.ai, Harrison.ai builds technology designed to augment radiologists, streamline workflows, and deliver measurable clinical and operational impact.
At the core of its offering is the Harrison.ai Open Platform—a first-of-its-kind, open-architecture environment that supports both Harrison’s native applications and third-party algorithms within a single, unified interface. Built for transparency and collaboration, the platform aligns incentives between developers and healthcare providers, fostering innovation while avoiding vendor lock-in.
Harrison.ai also delivers a comprehensive Chest CT solution, capable of detecting up to 167 thoracic findings in one integrated workflow. From pulmonary embolism and lung nodules to effusions and aortic aneurysms, the solution enables faster prioritization, improved diagnostic confidence, and more efficient case review.
A major advancement in the portfolio is AI-powered draft report generation, which automates the transition from detection to documentation by producing fully structured, clinically sound draft reports in seconds. Independent evaluations by Mass General Brigham AI Arena and the American College of Radiology found that radiologists could not reliably distinguish AI-generated reports from human-written ones.
Complementing its clinical tools, the Harrison AI Value Calculator helps healthcare leaders quantify ROI using real-world operational metrics such as reporting time, outsourcing costs, and patient volumes—turning AI adoption into a clear, data-driven business case.
Together, Harrison.ai’s solutions empower radiology teams to work faster, smarter, and more confidently—supporting better patient outcomes while delivering tangible value at scale.
